Danaher Corporation reported a 60% year-over-year increase in Q2 2026 net earnings to $870 million, driven by strong core growth and the early completion of its Masimo acquisition. Revenues rose 5.5% to $6.3 billion, with adjusted earnings per share up 8% to $1.94. The company raised its full-year adjusted earnings per share guidance to $8.45-$8.60, expecting mid-single-digit core revenue growth by year-end. Danaher highlighted robust Life Sciences performance and ongoing market recovery as key growth drivers.
Danaher Corporation reported stronger-than-expected Q2 2026 earnings and revenue, driven by its Life Sciences segment, with EPS of $1.94 and revenue of $6.27 billion beating estimates. However, the stock fell nearly 12% in premarket trading due to in...
Wall Street is preparing for a volatile week with major earnings reports from Big Tech companies like Alphabet and Tesla, which are seen as key tests for the AI-driven market rally. Over 70 S&P 500 companies, including IBM, Intel, and American Expres...
